Lucie Coppin

694 total citations
25 papers, 421 citations indexed

About

Lucie Coppin is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Lucie Coppin has authored 25 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Lucie Coppin's work include Neuroendocrine Tumor Research Advances (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Lung Cancer Research Studies (5 papers). Lucie Coppin is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Lung Cancer Research Studies (5 papers). Lucie Coppin collaborates with scholars based in France, Australia and Mexico. Lucie Coppin's co-authors include Pascal Pigny, Marie‐Françoise Odou, Audrey Vincent, Nicole Porchet, Julie Leclerc, Marie‐Christine Vantyghem, Isabelle Van Seuningen, Arnaud Jannin, Emmanuelle Leteurtre and Stéphanie Espiard and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lucie Coppin

24 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucie Coppin France 14 177 140 94 70 59 25 421
Rosj Rosas Italy 8 104 0.6× 122 0.9× 76 0.8× 69 1.0× 18 0.3× 9 320
Shinsuke Uraki Japan 12 104 0.6× 138 1.0× 99 1.1× 27 0.4× 42 0.7× 33 441
Sara Molatore Italy 12 226 1.3× 221 1.6× 132 1.4× 130 1.9× 11 0.2× 16 537
Kate E Lines United Kingdom 15 175 1.0× 267 1.9× 315 3.4× 91 1.3× 20 0.3× 41 609
Aaron C. Haran United States 5 159 0.9× 52 0.4× 123 1.3× 55 0.8× 35 0.6× 6 411
Natasha Jeffs United Kingdom 3 202 1.1× 230 1.6× 34 0.4× 56 0.8× 102 1.7× 3 456
Cosima Quatraro Italy 11 190 1.1× 146 1.0× 76 0.8× 35 0.5× 240 4.1× 11 546
Patricia Q. Rodriguez Sweden 9 189 1.1× 64 0.5× 38 0.4× 60 0.9× 39 0.7× 20 357
Weijie Poh United States 10 335 1.9× 191 1.4× 66 0.7× 191 2.7× 33 0.6× 19 529

Countries citing papers authored by Lucie Coppin

Since Specialization
Citations

This map shows the geographic impact of Lucie Coppin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucie Coppin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucie Coppin more than expected).

Fields of papers citing papers by Lucie Coppin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucie Coppin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucie Coppin. The network helps show where Lucie Coppin may publish in the future.

Co-authorship network of co-authors of Lucie Coppin

This figure shows the co-authorship network connecting the top 25 collaborators of Lucie Coppin. A scholar is included among the top collaborators of Lucie Coppin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucie Coppin. Lucie Coppin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romanet, Pauline, et al.. (2025). Chapter 5: The roles of genetics in primary hyperparathyroidism. Annales d Endocrinologie. 86(1). 101694–101694. 3 indexed citations
2.
Jannin, Arnaud, Sophie Dabo‐Niang, Christine Do Cao, et al.. (2025). Identification of metabolite biomarkers for pancreatic neuroendocrine tumours using a metabolomic approach. European Journal of Endocrinology. 192(4). 466–480.
3.
Cardot-Bauters, Catherine, Marie‐Christine Vantyghem, Christine Do Cao, et al.. (2024). Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the field. Annales d Endocrinologie. 85(4). 276–283. 1 indexed citations
4.
Jannin, Arnaud, Anne‐Frédérique Dessein, Christine Do Cao, et al.. (2023). Metabolism of pancreatic neuroendocrine tumors: what can omics tell us?. Frontiers in Endocrinology. 14. 1248575–1248575. 7 indexed citations
5.
Lagarde, Arnaud, Lucie Coppin, Magalie Haissaguerre, et al.. (2022). Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms. Endocrine Connections. 11(11). 12 indexed citations
6.
Souidi, Mouloud, Bélinda Duchêne, Bernadette Neve, et al.. (2021). Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma. Cancers. 13(24). 6197–6197. 7 indexed citations
7.
Barraud, Sara, Lucie Coppin, D. Zachar, et al.. (2021). A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features. Endocrine. 73(3). 693–701. 4 indexed citations
8.
Jonckheere, Nicolas, Lucie Coppin, Audrey Vincent, et al.. (2020). Unsupervised Hierarchical Clustering of Pancreatic Adenocarcinoma Dataset from TCGA Defines a Mucin Expression Profile that Impacts Overall Survival. Cancers. 12(11). 3309–3309. 17 indexed citations
9.
Coppin, Lucie, Arnaud Jannin, Emilie Ait‐Yahya, et al.. (2020). Galectin-3 modulates epithelial cell adaptation to stress at the ER-mitochondria interface. Cell Death and Disease. 11(5). 360–360. 24 indexed citations
10.
Coppin, Lucie, Michel Crépin, Anne‐Sophie Jourdain, et al.. (2019). Optimization of Next-Generation Sequencing Technologies for von Hippel Lindau (VHL) Mosaic Mutation Detection and Development of Confirmation Methods. Journal of Molecular Diagnostics. 21(3). 462–470. 17 indexed citations
11.
Romanet, Pauline, Sophie Giraud, Marie‐Françoise Odou, et al.. (2019). UMD-MEN1 database: analysis of clinical and genetic data from 1,676 patients by the TENGEN network. Endocrine Abstracts. 1 indexed citations
12.
Coppin, Lucie, Julie Leclerc, Audrey Vincent, Nicole Porchet, & Pascal Pigny. (2018). Messenger RNA Life-Cycle in Cancer Cells: Emerging Role of Conventional and Non-Conventional RNA-Binding Proteins?. International Journal of Molecular Sciences. 19(3). 650–650. 39 indexed citations
13.
Drubay, V, Nicolas Skrypek, Céline Schulz, et al.. (2018). TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727. Cancers. 10(8). 254–254. 19 indexed citations
14.
Kern, Benjamin, Lucie Coppin, Pauline Romanet, et al.. (2017). Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of “thyroid-checked” controls. European Journal of Medical Genetics. 60(3). 178–184. 10 indexed citations
15.
Coppin, Lucie, Audrey Vincent, Frédéric Frénois, et al.. (2017). Galectin-3 is a non-classic RNA binding protein that stabilizes the mucin MUC4 mRNA in the cytoplasm of cancer cells. Scientific Reports. 7(1). 43927–43927. 33 indexed citations
16.
Espiard, Stéphanie, et al.. (2017). Diseases associated with calcium-sensing receptor. Orphanet Journal of Rare Diseases. 12(1). 19–19. 60 indexed citations
17.
d’Herbomez, Michèle, et al.. (2016). Biomarkers of neuroendocrine tumors. Annales de biologie clinique. 74(6). 669–679. 8 indexed citations
18.
Coppin, Lucie, Stéphane Cattan, Florence Renaud, et al.. (2015). CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases. Pancreatology. 16(1). 115–120. 20 indexed citations
19.
Renaud, Florence, Viviane Gnemmi, Patrick Devos, et al.. (2014). MUC1 Expression in Papillary Thyroid Carcinoma Is Associated with BRAF Mutation and Lymph Node Metastasis; the Latter is the Most Important Risk Factor of Relapse. Thyroid. 24(9). 1375–1384. 15 indexed citations
20.
Coppin, Lucie, Michel Crépin, Sophie Giraud, et al.. (2013). VHL mosaicism can be detected by clinical next-generation sequencing and is not restricted to patients with a mild phenotype. European Journal of Human Genetics. 22(9). 1149–1152. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosj Rosas Breakdown of academic impact, for papers by Shinsuke Uraki Breakdown of academic impact, for papers by Sara Molatore Breakdown of academic impact, for papers by Kate E Lines Breakdown of academic impact, for papers by Aaron C. Haran Breakdown of academic impact, for papers by Natasha Jeffs Breakdown of academic impact, for papers by Cosima Quatraro Breakdown of academic impact, for papers by Patricia Q. Rodriguez Breakdown of academic impact, for papers by Weijie Poh
Rankless by CCL
2026